Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST)
2014-000096-80Phase 3Completed
- Sponsor
- University or Tromsø
- Start
- May 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of tenecteplase in ischemic stroke and brain infarction (2 arms), sponsored by University or Tromsø. Primary endpoint: Functional outcome. Started May 2016; status: completed.
02
Drugs
tenecteplase
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on 2014-000096-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000096-80.